Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,935,305,104
+$799,318,317 QoQ
Shares Held
15,638,631
+8.5% QoQ
Ownership
0.885%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#16
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International Investors holds $21,276,574,646 across 8 Drug Manufacturers - General names. ABBV ranks #3 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,734,768 | $6,878,453,355 | |
| 2 | AZN |
Astrazeneca PLC
|
34,576,070 | $6,556,314,393 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
15,638,631 | $3,935,305,104 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,386,689 | $1,977,189,536 | |
| 5 | AMGN |
Amgen Inc
|
1,668,778 | $604,297,889 | |
| 6 | JNJ |
Johnson & Johnson
|
2,040,519 | $518,230,610 | |
| 7 | NVO |
Novo Nordisk A S
|
9,721,180 | $466,033,369 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,913,752 | $340,750,390 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,935,305,104 | 15,638,631 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,135,986,787 | 14,418,993 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,671,679,874 | 11,692,765 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,478,295,799 | 10,703,532 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,533,976,951 | 13,651,422 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,302,855,669 | 20,536,730 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,070,400,817 | 28,533,488 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $7,264,863,433 | 36,787,844 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,621,046,599 | 38,602,184 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,758,788,566 | 48,098,784 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,971,818,719 | 44,988,183 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,326,959,023 | 42,445,720 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,813,968,794 | 43,152,741 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,812,806,451 | 42,748,362 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,611,605,877 | 47,098,607 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,150,476,296 | 45,827,258 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,609,638,332 | 43,155,121 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,943,993,008 | 30,497,767 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $1,572,680,207 | 11,615,068 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,046,513,425 | 9,701,617 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,092,459,653 | 9,698,683 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,049,736,597 | 9,700,024 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $843,444,190 | 7,871,621 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $875,558,399 | 9,996,100 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,128,034,201 | 11,489,450 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $607,496,850 | 7,973,446 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||